Patient Organization Collaboration Promotion Committee Patient Organization Advisory Board Past Meeting Summaries
-
What is and should be the way of providing information on pharmaceutical products?
-
Introduction from the Pharmaceutical Association and exchange of opinions on drug development (clinical trials)
-
Exchange of opinions on expectations and requests to the pharmaceutical industry with newly appointed advisors
-
Visit to Takeda's Shonan Research Center and exchange of opinions
-
Opinion exchange on "Legislation on Clinical Research" and "Questionnaire on Medical Information
Ikuo Miyamoto, Leader of MA/Clinical Research TF, Pharmaceutical Evaluation Committee, Pharmaceutical Association of Japan
Masaya Takamoto, Leader of TF for "Industrial Vision 2025", Patient Group Collaboration Promotion Committee, Pharmaceutical Association of Japan
Yasuhiro Marumoto, Leader of Questionnaire TF, Patient Group Collaboration Promotion Committee, Pharmaceutical Association of Japan -
Opinion exchange on "Pharmaceutical Association of Japan Industry Vision 2025" and "Trial introduction of cost-effectiveness evaluation
Kazuhiro Momose, Leader of Vision Promotion Project, Industrial Policy Committee, Pharmaceutical Association of Japan
Reitsune Miura, Leader of Medical Technology Evaluation Group, Industrial Promotion Subcommittee, Industrial Policy Committee, Pharmaceutical Association of Japan